1. Home
  2. RMI vs CPIX Comparison

RMI vs CPIX Comparison

Compare RMI & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RiverNorth Opportunistic Municipal Income Fund Inc.

RMI

RiverNorth Opportunistic Municipal Income Fund Inc.

N/A

Current Price

$12.96

Market Cap

87.4M

Sector

Finance

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$6.36

Market Cap

98.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RMI
CPIX
Founded
N/A
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.4M
98.3M
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
RMI
CPIX
Price
$12.96
$6.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.9K
★ 195.2K
Earning Date
01-01-0001
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ 4.60
Revenue
N/A
★ $42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$1.27
Revenue Growth
N/A
★ 16.75
52 Week Low
$13.07
$1.92
52 Week High
$16.36
$9.28

Technical Indicators

Market Signals
Indicator
RMI
CPIX
Relative Strength Index (RSI) 29.11 53.06
Support Level N/A $5.76
Resistance Level $14.17 $7.93
Average True Range (ATR) 0.21 0.78
MACD -0.09 0.21
Stochastic Oscillator 5.22 69.04

Price Performance

Historical Comparison
RMI
CPIX

About RMI RiverNorth Opportunistic Municipal Income Fund Inc.

RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: